It has been found that the expression of two downstream target genes of P53 decreased after ARID1A silencing in GC cells, indicating that ARID1A and P53 may synergistically activate the transcription of target genes and inhibit tumor growth [57], which confirmed the previous view of Guan in ovarian cancer research [58]. The gene discussed is ARID1A; the disease is ovarian carcinoma.